Wellmarker Bio

Developer of anticancer drugs designed to treat cancer patients with medical advancement. The company specializes in developing predictive biomarkers and first-in-class drugs through profound research...

Healthcare

Hanam, South Korea

Founded 2016

7 employees

Website

Valuation

Share Price

N/A

Total Raised

$41.9M

Last Round

N/A

Investors

+28 other investors

View all 28 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Wellmarker Bio's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required